Abali H - Search Results

1

Can effectiveness of allogeneic transplantation be predicted in advance?

Abali H, Oksuzoglu B, Yildirim N, Budakoglu B. Abali H, et al. Med Hypotheses. 2005;64(2):430-1. doi: 10.1016/j.mehy.2004.09.008. Med Hypotheses. 2005. PMID: 15607583 No abstract available.

2

Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.

Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N. Abali H, et al. Cancer Invest. 2008 May;26(4):401-6. doi: 10.1080/07357900701788098. Cancer Invest. 2008. PMID: 18443961

3

Good tolerance of weekly irinotecan in a patient with metastatic colorectal cancer on chronic hemodialysis.

Budakoglu B, Abali H, Uncu D, Yildirim N, Oksüzoglu B, Zengin N. Budakoglu B, et al. Among authors: abali h. J Chemother. 2005 Aug;17(4):452-3. doi: 10.1179/joc.2005.17.4.452. J Chemother. 2005. PMID: 16167527

4

Primary duodenal diffuse large cell non-hodgkin lymphoma with involvement of ampulla of Vater: report of 3 cases.

Yildirim N, Oksüzoğlu B, Budakoğlu B, Vural M, Abali H, Uncu D, Zengin N. Yildirim N, et al. Among authors: abali h. Hematology. 2005 Oct;10(5):371-4. doi: 10.1080/10245330500168773. Hematology. 2005. PMID: 16273723 Free article.

5

An extraordinary case in whom gastrointestinal stromal tumor and low-grade malignant lymphoma are seen together in the stomach.

Pamukçuoglu M, Budakoğlu B, Han O, Tad M, Oksüzoğlu B, Abali H, Zengin N. Pamukçuoglu M, et al. Among authors: abali h. Med Oncol. 2007;24(3):351-3. doi: 10.1007/s12032-007-0001-4. Med Oncol. 2007. PMID: 17873313

6

Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes.

Oksuzoglu B, Abali H, Hayran M, Yildirim N, Budakoglu B, Zengin N. Oksuzoglu B, et al. Among authors: abali h. Chemotherapy. 2008;54(5):352-6. doi: 10.1159/000151630. Epub 2008 Aug 26. Chemotherapy. 2008. PMID: 18728366 Clinical Trial.

7

Performance status scales may not correctly predict status of cancer patients with paraplegia.

Budakoglu B, Abali H, Oksüzoglu BC, Aksoy S, Zengin N. Budakoglu B, et al. Among authors: abali h. Cancer Invest. 2006 Mar;24(2):221-2. doi: 10.1080/07357900500524777. Cancer Invest. 2006. PMID: 16537194 No abstract available.

8

Disclosure of cancer diagnosis to patients and their relatives in Turkey: views of accompanying persons and influential factors in reaching those views.

Oksüzoğlu B, Abali H, Bakar M, Yildirim N, Zengin N. Oksüzoğlu B, et al. Among authors: abali h. Tumori. 2006 Jan-Feb;92(1):62-6. doi: 10.1177/030089160609200110. Tumori. 2006. PMID: 16683385

9

Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients.

Ozdemir N, Aksoy S, Sendur MA, Akinci MB, Yazici O, Budakoglu B, Abali H, Oksuzoglu B, Zengin N. Ozdemir N, et al. Among authors: abali h. J BUON. 2013 Oct-Dec;18(4):831-7. J BUON. 2013. PMID: 24344005 Free article.

10

It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting.

Ozdemir NY, Abali H, Oksüzoğlu B, Budakoğlu B, Akmangit I, Zengin N. Ozdemir NY, et al. Among authors: abali h. Support Care Cancer. 2009 Apr;17(4):399-403. doi: 10.1007/s00520-008-0498-x. Epub 2008 Sep 2. Support Care Cancer. 2009. PMID: 18762993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters